The global tally for the coronavirus-borne illness climbed above 255 million on Thursday, while the death toll edged above 5.12 million, according to data aggregated by Johns Hopkins University . The U.S. continues to lead the world with a total of 47.4 million cases and 767,435 deaths. The U.S. is still averaging more than 1,100 deaths a day, according to a New York Times tracker, although cases and hospitalizations are declining. Michigan and Minnesota are leading the nation by new cases on a per capital basis with caseloads up more than 60% in the last two weeks. AstraZeneca Plc /zigman2/quotes/200304487/composite AZN -1.78% /zigman2/quotes/203048482/delayed UK:AZN -1.02% said that Phase 3 trials of its AZD7442 antibody combination confirmed that the treatment reduces risk of developing symptomatic COVID, Dow Jones Newswires reported. The pharmaceutical company said the analysis of its continuing trial evaluating a median six months of participant follow-up revealed that one dose of AZD7442 showed 83% reduced symptomatic Covid-19 risk and no severe disease or deaths. India is second by cases after the U.S. at 34.5 million and has suffered 464,623 deaths. Brazil has second highest death toll at 611,851 and 21.9 million cases. In Europe, Russia has the most fatalities at 255,448 deaths, followed by the U.K. at 143,801.